logo-loader
Integumen

Integumen PLC builds out laboratory capacity as it bags three new contracts

Integumen PLC’s (LON:SKIN) Gerry Brandon caught up with Proactive London's Andrew Scott to discuss three new contracts they've won worth £290,000 in total.

The three new clients are a leading drug store chain, a European provider of beauty and household products, and the creator of CBD-infused tampons designed to fight period cramps.

To help accommodate the new business and the pipeline of potential orders, Integumen is increasing its laboratory capacity by 50%.

Quick facts: Integumen

Price: £0.02

Market: AIM
Market Cap: £16.66 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Integumen PLC well funded as it continues growth towards...

Integumen PLC (LON:SKIN) CEO Gerry Brandon talks Proactive London's Andrew Scott through the firm's first half numbers. Revenues from continuing operations had increased 540% to £346,697, while its EBITDA loss had fallen 32% to £370,102. That doesn't include RinoCloud revenues of £178,000...

1 week, 3 days ago

2 min read